These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23821002)

  • 1. BAG3 is a novel serum biomarker for pancreatic adenocarcinomas.
    Falco A; Rosati A; Festa M; Basile A; De Marco M; d'Avenia M; Pascale M; Dal Piaz F; Tavano F; Di Mola FF; di Sebastiano P; Berloco PB; Nudo F; Caraglia M; Febbraro A; Barcaroli D; Scarpa A; Pezzilli R; De Laurenzi V; Turco MC
    Am J Gastroenterol; 2013 Jul; 108(7):1178-80. PubMed ID: 23821002
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer.
    Joergensen MT; Heegaard NH; Schaffalitzky de Muckadell OB
    Pancreas; 2010 Mar; 39(2):243-7. PubMed ID: 19820423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
    Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
    Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
    Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of serum biomarker signatures associated with pancreatic cancer.
    Wingren C; Sandström A; Segersvärd R; Carlsson A; Andersson R; Löhr M; Borrebaeck CA
    Cancer Res; 2012 May; 72(10):2481-90. PubMed ID: 22589272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary and Pancreatic: Pancreatic cancer with elevated serum IgG4 level due to multiple myeloma mimicking localized autoimmune pancreatitis.
    Kato S; Kuwatani M; Kawakubo K; Sugiura R; Hirata K; Tanikawa S; Mitsuhashi T; Shiratori S; Sakamoto N
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1310. PubMed ID: 29761833
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis: cost effectiveness of IgG4.
    Hughes DB; Grobmyer SR; Brennan MF
    Pancreas; 2004 Aug; 29(2):167. PubMed ID: 15257110
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Gao H; Zheng Z; Yue Z; Liu F; Zhou L; Zhao X
    Int J Mol Med; 2012 Nov; 30(5):1061-8. PubMed ID: 22941199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.
    Fong ZV; Winter JM
    Cancer J; 2012; 18(6):530-8. PubMed ID: 23187839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay.
    Liberati D; Marzinotto I; Brigatti C; Dugnani E; Pasquale V; Reni M; Balzano G; Falconi M; Piemonti L; Lampasona V
    Cancer Biomark; 2018; 22(2):351-357. PubMed ID: 29660901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human complement factor B as a novel biomarker candidate for pancreatic ductal adenocarcinoma.
    Lee MJ; Na K; Jeong SK; Lim JS; Kim SA; Lee MJ; Song SY; Kim H; Hancock WS; Paik YK
    J Proteome Res; 2014 Nov; 13(11):4878-88. PubMed ID: 25057901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular markers in pancreatic cancer diagnosis.
    Herreros-Villanueva M; Gironella M; Castells A; Bujanda L
    Clin Chim Acta; 2013 Mar; 418():22-9. PubMed ID: 23305796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An animal model of preclinical diagnosis of pancreatic ductal adenocarcinomas.
    Fukamachi K; Tanaka H; Hagiwara Y; Ohara H; Joh T; Iigo M; Alexander DB; Xu J; Long N; Takigahira M; Yanagihara K; Hino O; Saito I; Tsuda H
    Biochem Biophys Res Commun; 2009 Dec; 390(3):636-41. PubMed ID: 19818733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
    Xue A; Gandy RC; Chung L; Baxter RC; Smith RC
    Pancreatology; 2012; 12(2):124-9. PubMed ID: 22487522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A and B blood group antigens in human pancreatic ductal adenocarcinomas.
    Handra-Luca A
    Oncology; 2013; 84(3):141-9. PubMed ID: 23257765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
    Kondo N; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Shigemoto N; Kato Y; Ohge H; Sueda T
    Ann Surg Oncol; 2010 Sep; 17(9):2321-9. PubMed ID: 20336387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein?
    Meggiato T; Basso D; Fabris C; Fogar P; Panozzo MP; Plebani M; Faggian D; Scalon P; Ferrara C; Del Favero G
    Dis Markers; 1990; 8(4):171-7. PubMed ID: 1708317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer.
    Basile A; De Marco M; Festa M; Falco A; Iorio V; Guerriero L; Eletto D; Rea D; Arra C; Lamolinara A; Ballerini P; Damiani V; Rosati A; Sala G; Turco MC; Marzullo L; De Laurenzi V
    Mol Oncol; 2019 Jun; 13(6):1388-1399. PubMed ID: 30973679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation profile of circulating plasma DNA in patients with pancreatic cancer.
    Melnikov AA; Scholtens D; Talamonti MS; Bentrem DJ; Levenson VV
    J Surg Oncol; 2009 Feb; 99(2):119-22. PubMed ID: 19065635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.